Xu WH - Search Results

1

Biomarkers of Renal Tumors: the Current State and Clinical Perspectives.

Golovastova MO, Korolev DO, Tsoy LV, Varshavsky VA, Xu WH, Vinarov AZ, Zernii EY, Philippov PP, Zamyatnin AA Jr. Golovastova MO, et al. Among authors: xu wh. Curr Urol Rep. 2017 Jan;18(1):3. doi: 10.1007/s11934-017-0655-1. Curr Urol Rep. 2017. PMID: 28110463 Review.

2

Identifying prognostic biomarkers based on aberrant DNA methylation in kidney renal clear cell carcinoma.

Chen G, Wang Y, Wang L, Xu W. Chen G, et al. Oncotarget. 2017 Jan 17;8(3):5268-5280. doi: 10.18632/oncotarget.14134. Oncotarget. 2017. PMID: 28029655 Free PMC article.

3

miR-93-3p inhibition suppresses clear cell renal cell carcinoma proliferation, metastasis and invasion.

Wang L, Yang G, Zhu X, Wang Z, Wang H, Bai Y, Sun P, Peng L, Wei W, Chen G, Li G, Zamyatnin AA Jr, Glybochko PV, Xu W. Wang L, et al. Oncotarget. 2017 Aug 24;8(47):82824-82834. doi: 10.18632/oncotarget.20458. eCollection 2017 Oct 10. Oncotarget. 2017. PMID: 29137305 Free PMC article.

4

Advances in the Development of Anticancer HSP-based Vaccines.

Baldin AV, Zamyatnin AA Jr, Bazhin AV, Xu WH, Savvateeva LV. Baldin AV, et al. Among authors: xu wh. Curr Med Chem. 2019;26(3):427-445. doi: 10.2174/0929867325666180129100015. Curr Med Chem. 2019. PMID: 29376489 Review.

5

Mutational analysis of proto-oncogene Dbl on Xq27 in testicular germ cell tumors reveals a rare SNP in a patient with bilateral undescended testis.

Xu WH, Zhang C, Zhao WM, Li CM, Xiu YC, Ni SB, Ren MH, Sun DJ. Xu WH, et al. World J Urol. 2009 Dec;27(6):811-5. doi: 10.1007/s00345-009-0408-y. World J Urol. 2009. PMID: 19373475

6

Periurethral injection of autologous adipose-derived stem cells with controlled-release nerve growth factor for the treatment of stress urinary incontinence in a rat model.

Zhao W, Zhang C, Jin C, Zhang Z, Kong D, Xu W, Xiu Y. Zhao W, et al. Eur Urol. 2011 Jan;59(1):155-63. doi: 10.1016/j.eururo.2010.10.038. Epub 2010 Oct 26. Eur Urol. 2011. PMID: 21050657

7

Preclinical optimization of a broad-spectrum anti-bladder cancer tri-drug regimen via the Feedback System Control (FSC) platform.

Liu Q, Zhang C, Ding X, Deng H, Zhang D, Cui W, Xu H, Wang Y, Xu W, Lv L, Zhang H, He Y, Wu Q, Szyf M, Ho CM, Zhu J. Liu Q, et al. Sci Rep. 2015 Jun 19;5:11464. doi: 10.1038/srep11464. Sci Rep. 2015. PMID: 26088171 Free PMC article.

8

MicroRNA-195 targets VEGFR2 and has a tumor suppressive role in ACHN cells via PI3K/Akt and Raf/MEK/ERK signaling pathways.

Sun P, Wang L, Lu Y, Liu Y, Li L, Yin L, Zhang C, Zhao W, Shen B, Xu W. Sun P, et al. Int J Oncol. 2016 Sep;49(3):1155-63. doi: 10.3892/ijo.2016.3608. Epub 2016 Jul 6. Int J Oncol. 2016. PMID: 27572273

9

Roles of Loss of Chromosome 14q Allele in the Prognosis of Renal Cell Carcinoma with C-reactive Protein Abnormity.

Wang G, Zhang DM, Zhuang HY, Yin C, Liu J, Wang ZC, Cai LC, Ren MH, Xu WH, Zhang C. Wang G, et al. Among authors: xu wh. Chin Med J (Engl). 2017 Sep 20;130(18):2176-2182. doi: 10.4103/0366-6999.213962. Chin Med J (Engl). 2017. PMID: 28875953 Free PMC article.

10

MicroRNA-30a-5p Inhibits the Growth of Renal Cell Carcinoma by Modulating GRP78 Expression.

Wang C, Cai L, Liu J, Wang G, Li H, Wang X, Xu W, Ren M, Feng L, Liu P, Zhang C. Wang C, et al. Cell Physiol Biochem. 2017;43(6):2405-2419. doi: 10.1159/000484394. Epub 2017 Oct 27. Cell Physiol Biochem. 2017. PMID: 29073630 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

661 results

Search Page